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Paraphenylenediamine (PPD) is a frequent
and potent sensitizer producing many cases
of allergic eczematous contact-type dermatitis.
A review of the patient material of our Al-
lergy Section from 1949 through 1956 reveals
that PPD is one of the most common causes
of patch test reactions. Of 712 patients referred
to the Allergy Section for patch testing during
1956 who were tested to PPD, 26 (3.6%) gave
strongly positive (3 or 4+) reactions.
PPD (H2N-C6H4-NH2) is used principally
in hair and fur dying. It may cross react, al-
lergenically or immunologically, with other
chemicals having an amino grouping in the para
position on the benzene ring. These include cer-
tain dyes, local anesthetics, para-aminobenzoie
acid and the sulfonamides.
This paper deals with the persistence of PPD
sensitivity, some aspects of the cross sensitivity
pattern of this substance, and the clinical signifi-
cance of these findings.
METHODS AND REsULTS
In 1956, 50 patients with positive patch test
reactions to PPD during the period from 1946
to 1953 returned to the Allergy Section for
further investigation. The group consisted of
38 women and 12 men, ranging in age from 18
to 70. 18 had had 4+ reactions, 26 had had 3+
reactions, 6 had had 2+ reactions. In 1956
these patients were patch tested with 2% PPD
in petrolatum, 5% benzocaine in petrolatum, 1%
aqueous procaine hydrochloride, 5% para-amino-
benzoic acid( PABA) in petrolatum, and 5% sulf-
anilimide in petrolatum. The patients were care-
fully questioned concerning exposures and
reactions to nylon stockings, hair dyes, local an-
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esthetics, sun screens, and sulfa drugs. 46 of the
50 patients still reacted to PPD. All the 4+ re-
actors and all but one of the 3 + reactors had
retained their hypersensitivity to this chem-
ical. In contrast 3 of the 6 2+ reactors no
longer manifested any sensitivity to PPD.
Table II shows the other positive patch test
reactions of the 46 patients who retained their
PPD hypersensitivity. 28 reacted only to PPD
and showed no cross-reactions to any of the
other test substances. 11 patients reacted to
both PPD and benzocaine. 4 patients reacted
to PPD, procaine and benzoeaine. 3 patients
reacted to PPD, PABA and benzoeaine. One
of these reacted to procaine as well. One patient
reacted to sulfanilamide and PPD. In addition,
25 patients with strong positive patch tests to
PPD were patch tested with two recently in-
troduced cral anti-diabetic eompounds* which
are structurally related to sulfanilamide. There
were no reactions to these sulfa compounds
in any of these PPD positive patients.
DISCUSSION
43 of 44 persons who had shown 3+ or 4-F
patch test reactions to PPD during the years
1946—53 still manifested this sensitivity when
they were retested with PPD in 1956. 3 of 6
persons who had shown weaker (2+) reactions
during the initial period were negative to PPD
patch tests in 1956. Table III compares the
persistence over a 3 to 10 year period of strong
PPD sensitivity with that of other allergens
similarly studied. Once established, allergic
hypersensitivity to many simple chemicals is
maintained for long periods of time (1—3).
However "spontaneous" loss of sensitivity to
some allergens has been observed (4). The
persistence of allergic eezematous contact-type
sensitization varies from substance to substance.
PPD appears to belong with benzocaine, nickel,
*5% Carbutamide (1 butyl-3-p-aminobenzesul-fonurea) in petrolatum and 5% tolbutamide.
(1 -butyl-3-p-tolysulfonurea) in petrolatum. These
tests were suggested by Dr. R. L. Baer, who sup-
plied the materials for patch testing.
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TABLE I
The persistence of PPD sensitivity in 50 patients
During the Period 1946—1953
50 PPD Positive Patients
Showed These Reactions
When Re-tested in 1956
The Same Patients Showed
These Reactions
4+ 18 4+
3+
13
5
3+ 26 3+
2+
Nag
17
8
1
2+ 6 1—2+
Nag
3
3
TABLE II
Number of cross reactions in 46 individuals
with PPD hypersensitivity
PPD alone—no cross reactions. . . 28
PPD and benzocaine 11
PPD procaine and benzocaine... 4*
PPD, PABA and benzocaine.... 3t
Sulfanilamide 1
* Procaine reactors all reacted to benzocaine.
I One of these reacted to procaine as well.
TABLE III
Comparison of persistence of strong PPD sensitivity
over a period of 3 to 10 years with that of benzo-
caine, nickel sulphate, ragweed oleoresin and
potassium dichromate
No. of
Cases
Persistant
Positives
PPD
Benzocaine
Nickel
Ragweed oleoresin
Potassium dichromate
44
25
100
18
20
97%
96%
90%
100%
55%
and ragweed oleoreSin to that group of chemicals
in which allergic hypersensitivity may be re-
peatedly demonstrated years after the initial
sensitization has taken place. Hypersensitivity
to dichromate, on the other hand, is much less
consistently maintained over a period of years.
Any evaluation of desensitization procedures
must be based on a knowledge of the natural
persistence, or lack of persistence, of the hyper-
sensitivity to the substance in question.
Baer (5) suggested that repeated exposure to a
specific allergen might increase the level of sensi-
tivity to that substance. Several of the PPD posi-
tive women in this study repeatedly exposed
themselves to PPD (in hair dyes) without any
increase in their PPD sensitivity as measured by
patch tests. Repeated patch testing with PPD
also appeared to have no effect on the level of
sensitivity to the test substance.
11 of our 46 PPD positive patients were also
sensitive to benzocaine. Many of these patients
had been exposed to both allergens so it was
not possible to determine which substance was
the primary allergen. These findings agree
generally with those of Tzanck, Sidi, and Dob-
kevitch-Morrill (6) who reported that a minority
of their patients with a 'primary' sensitization to
PPD developed cross-reactions to local an-
esthetics. On the other hand, these investigators
reported that a majority of their patients with
'primary' sensitization to local anesthetics mani-
fested cross-sensitization to PPD. We found in a
separate study of 24 benzocaine positive patients
in whom it appeared probable that benzocaine
was the 'primary' allergen, that 10 showed hyper-
sensitivity to PPD as well.
All three of our patients who reacted to both
PPD and procaine also reacted to benzocaine.
Baer (7) reported that three of seven PPD
positive patients reacted to both procaine and
benzocaine. Sidi and Dobkevitch-Morrill (8)
also reported seven patients who reacted to PPD
and procaine and ointments containing local
anesthetics (not benzocaine). The possibility
that 'primary' sensitization to PPD or benzo-
caine may pave the way for severe reactions to
procaine administered at a later date will be
dealt with more fully in another publication.
It has been suggested that repeated exposure
to a specific allergen might widen the spectrum
of sensitization (7). The patient-material re-
viewed in this paper includes 5 PPD positive
women who repeatedly exposed themselves to
this material over a period of several years. These
exposures always caused a severe dermatitis.
These patients showed no widening of their
spectmm of sensitivity. They maintained hyper-
sensitivity to PPD and did not react to the other
related compounds with which we tested them.
Nor did repeated patch testing of these PPD
positive patients with other compounds con-
taining the para-amino benzyl grouping sen-
sitize to the other compounds.
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Our study indicates that PPD sensitivity,
once established, persists for years. The spectrum
of cross sensitivity to PPD appears to be related
to an individual "host" factor and to be estab-
lished early. The spectrum of cross sensitivity
does not as a rule widen later even with re-
peated exposure to the allergens in question.
Only one of our patients showed a "spread",
or widening, of his PPD sensitivity to henzo-
caine and procaine over a three year period. A
broad pattern of cross sensitivity seems to be
the exception rather than the rule. There was
no difference in the findings between the younger
and the older age groups in our material.
Baer (7) has pointed out the unpredictability
of an individual's pattern of sensitization. No
two of his 9 PPD positive patients showed
identical patterns when tested to 20 related
allergens. Strauss (9) concluded that only patch
testing or clinical exposure can determine
whether a hypersensitive individual will react
to one or more or all of a group of related com-
pounds. Furthermore in cases of multiple reac-
tions of cross sensitivity, it may be very difficult
or impossible to determine the 'primary' allergen
if there has been exposure to several of the re-
lated substances.
SUMMARY
3.6 per cent of 712 patients referred to the
Allergy Section of the New York Skin and Can-
cer Unit and patch tested with 2 per cent PPD
in petrolatum showed strongly positive (3—4+)
reactions to this allergen.
46 of 50 patients with strong hypersensitivity
to PPD retained this sensitivity over a period of
3 to 10 years. In this series of 46 PPD reactors,
there were 11 who gave cross-reactions to benzo-
caine, 4 who gave cross-reactions to procaine
and benzocaine, 3 who reacted to PABA and
benzocaine, and 1 who reacted to sulfanilimide.
Repeated exposure to PPD did not affect
the level of PPD sensitivity of the patients in
this series.
Repeated exposure to PPD and/or related
allergens did not, as a rule, broaden the estab-
lished spectrum of cross-sensitivity of the patients
studied in this series.
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DISCUSSION
DR. FRRDRRIcK REIS5 (New York, N. Y.):
Dr. Sulzberger pointed out before, studies on
sensitivity are an endless task of research and
Dr. Fisher demonstrated in his work how chal-
lenging this problem is.
We recently have published our investigation
on patch testing with oxidation hair dyes on
over 1,000 hospitalized patients. (J. of Allergy
28: 134, 1957). We used the paraphenylenedia-
mine and the paratoluylenediamine. Among 1,028
patients, only S patients showed a positive reac-
tion. Four reacted positively to paraphenyldia-
mine and three to paratoluylenediamine, and
one reacted to both dyes. This illustrates the
high specificity of sensitized patients.
An interesting factor in this series is that none
of these patients had previously used hair dye,
which indicates some sort of cross-sensitization
to certain substances we have not elicited. It
also has been our interest to investigate cross-
sensitizing phenomenon. For that purpose we
used procaine. Amongst the 8 positive reactors
only 2 showed positive reaction to procaine. On
retesting 301 patients at intervals of from three
to four weeks, once on 301 persons and twice
on 67 persons, no change developed in the speci-
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ficity of the reaction. In only one patient who
was found sensitive to the dye, early repetition
gave weaker reactions and the repetition on
three occasions a year later gave negative results.
DR. R. L. MAYER (Summit, N. J.): Sensitiza-
tion patterns of various compounds belonging to
the same antigenic group are most variable;
this is one of the most curious aspects of the
sensitization problem. It is a priori quite difficult
to understand why patients primarily sensitized
to p-phenylenediamine are more often sensitive
to procaine than vice versa. The reasons for the
existence of various patterns within a specific
type of cross-sensitization is probably due to
the fact that the sensitization is not caused by
the original substance, but by metabolites. It is
established that different metabolites are formed
within the same group; they all constitute direct
sensitizers of different potency. In the case of
p-phenylenediamine, for instance, and of com-
pounds related to it, the antigenic active metabo-
lites are all compounds of quinone structure,
and I have for this reason called this sensitiza-
tion the "Group Sensitivity to Compounds of
Quinone Structure". But even in the special
case of p-phenylenediamine, a variety of such
quinones may arise in the body, such as quinone
diimine, imino quinone, benzo quinone, oxy-
imino quinone, etc. Many factors determine
the nature of this intermediate, among them pH,
intensity of metabolism, type of exposure, etc.
These variations explain, in my opinion, the
various patterns of cross sensitivity. It would be
quite interesting to determine in each case of
sensitization the real chemical nature of the
intermediate responsible for the sensitization,
but this is, of course, a quite difficult problem.
DR. ALEXANDER A. FISHER (in closing): Dr.
Reiss mentioned the incidence of PPD sensi-
tivity. In our series there were 1712 patients
who were tested to PPD. 3.6 per cent reacted to
this substance. We interviewed some of the
beauty parlors in New York City to see how
many patients they rejected because of a posi-
tive patch test. The "better" beauty parlors
rejected 1 per cent.
I wish to thank Dr. Mayer for his discussion
on the role that intermediate products may
play in this sensitivity.
